Clinical Trial Update: 3Mixtatin and MTA Vital Pulpotomy in Primary Molars [Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 study evaluating 3Mixtatin paste and Mineral Trioxide Aggregate for vital pulpotomy in deciduous molars; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulpitis

Drugs mentioned

• 3Mixtatin (3Mixtatin paste (metronidazole, ciprofloxacin, minocycline))
• Mineral Trioxide Aggregate (MTA) (Mineral Trioxide Aggregate)

Snippet

Sponsor: Cairo University | Conditions: Pulp Disease, Dental, Deciduous Teeth | Phase 1 | Status: NOT_YET_RECRUITING